[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100592467":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":25,"locations":31,"responsibleParty":49,"collaborators":18,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":18,"eligibilityCriteria":59,"healthyVolunteers":55,"sex":60,"minAge":18,"maxAge":18,"enrollmentInfo":61,"targetDuration":18,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":71,"overallStatus":34,"whyStopped":18,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"University of California, Los Angeles","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"OPA Intervention Group","EXPERIMENTAL","Providers in this group will receive a Our Practice Advisory (OPA) through the electronic health record (EHR) system when ordering Hemoglobin A1c (A1c) and Thyroid-Stimulating Hormone (TSH) tests. The OPA will prompt providers to reconsider the test if it was ordered within the previous 30 days, aligning with evidence-based guidelines to reduce unnecessary testing.",[13],"Behavioral: OPA",{"label":15,"type":16,"description":17,"interventionNames":18},"Control Group","NO_INTERVENTION","Providers in this group will not receive a Our Practice Advisory (OPA) through the Electronic Health Record (EHR) system when ordering Hemoglobin A1c (A1c) and Thyroid-Stimulating Hormone (TSH) tests. This group represents the current standard of care, with no additional prompts or alerts implemented.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"BEHAVIORAL","OPA","The Our Practice Advisory (OPA) intervention is a behavioral nudge integrated into the electronic health record system. It is designed to prompt providers to reconsider ordering Hemoglobin A1c (A1c) and Thyroid-Stimulating Hormone (TSH) tests if a similar test was performed within the previous 30 days. The OPA aligns with evidence-based guidelines to reduce unnecessary testing, improve resource utilization, and optimize patient care by enhancing clinical decision-making at the point of order entry.",[9],[26],{"name":27,"role":28,"phone":29,"phoneExt":18,"email":30},"Katelyn Clinical Research Coordinator","CONTACT","310-267-5250","katenguyen@mednet.ucla.edu",[32],{"facility":33,"status":34,"city":35,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"UCLA Health System","RECRUITING","Los Angeles","California","90024","United States","US",{"type":41,"coordinates":42},"Point",[43,44],-118.24368,34.05223,{"lat":44,"lon":43},[47],{"name":48,"role":28,"phone":29,"phoneExt":18,"email":30},"Katelyn Clinical Research Coodinator",{"type":50,"investigatorFullName":51,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"PRINCIPAL_INVESTIGATOR","Catherine A. Sarkisian","Associate Professor of Medicine","100592467","evaluating-a-our-practice-advisory-opa-to-optimize-hemoglobin-a1c-a1c-and-thyroid-stimulating-hormone-tsh-test-orders-100592467",false,"NCT06993805","Evaluating a Our Practice Advisory (OPA) to Optimize Hemoglobin A1c (A1c) and Thyroid-Stimulating Hormone (TSH) Test Orders","Evaluation of Our Practice Advisory (OPA) Interventions on Hemoglobin A1c (A1c) and Thyroid-Stimulating Hormone (TSH) Short Interval Ordering","Inclusion Criteria:\n\n* 18 years or older\n* Inpatient or observation stays within UCLA Health System hospitals\n* Hemoglobin A1c (A1c) and Thyroid-Stimulating Hormone (TSH) ordered, AND this lab was ordered and resulted within the prior 30 days\n\nExclusion Criteria:\n\n* Have an A1c or TSH ordered and do not have a result for one of these labs in the prior 30 days","ALL",{"count":62,"type":63},384,"ESTIMATED","INTERVENTIONAL",[66],"NA","Our Practice Advisory (OPA) are essential tools in clinical decision-making. The alerts are designed to guide providers towards evidence-based practices and improve patient outcomes. The focus of this initiative is on Hemoglobin A1c (A1c) and Thyroid-Stimulating Hormone (TSH) testing, with the goal of addressing unnecessary repeat testing within a 30-day timeframe, which rarely yields significant new insights. Although randomization occurs at the patient level, the primary outcome of this study focuses on provider behavior and decision-making.\n\nBy focusing on this specific intervention, the study aims to optimize resource use, align test ordering with evidence-based guidelines, and support improved patient outcomes. The results of this evaluation will help refine OPAs and guide broader strategies for implementing clinical decision support tools across healthcare systems.",[69,70],"Physician Workflow","Resource Utilization",[72,73,70,74],"Clinical Decision Support","Laboratory Test Optimization","Our Practice Advisory (OPA)","2025-05-22",{"date":77,"type":78},"2025-05-29","ACTUAL",{"date":80,"type":78},"2025-05-06",{"date":82,"type":63},"2026-02",{"name":5,"class":6},1]